
Anixa Biosciences ANIX
$ 2.97
-2.62%
Quarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences Total Inventories 2011-2026 | ANIX
Quarterly Total Inventories Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 33.4 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 33.4 K | 33.4 K | 33.4 K |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
830 M | $ 115.62 | 0.06 % | $ 35.1 B | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
992 K | $ 1.65 | -1.2 % | $ 2.19 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 24.98 | 2.13 % | $ 694 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 21.85 | 2.92 % | $ 1.16 B | ||
|
Illumina
ILMN
|
547 M | $ 128.52 | 0.5 % | $ 20.4 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 84.11 | -0.26 % | $ 5.68 B | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 171.23 | 0.86 % | $ 8.49 B | ||
|
Guardant Health
GH
|
85.9 M | $ 88.5 | -0.46 % | $ 11.1 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 1.93 | -2.08 % | $ 8.54 M | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 7.27 | 3.12 % | $ 303 M | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
15 M | $ 52.75 | 0.06 % | $ 2.68 B | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.45 | -0.94 % | $ 2.05 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.18 | 1.87 % | $ 5.01 M | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 468.04 | -0.36 % | $ 176 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 103.21 | 1.02 % | $ 8.51 B | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 263.43 | -0.12 % | $ 21.9 B | ||
|
Twist Bioscience Corporation
TWST
|
28.3 M | $ 61.0 | 0.1 % | $ 3.65 B | ||
|
OpGen
OPGN
|
3.65 M | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.61 | 3.86 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 4.83 | 1.05 % | $ 447 M | ||
|
Natera
NTRA
|
35.4 M | $ 204.39 | 0.31 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 196.63 | 0.21 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M |